Trial Profile
Abacavir pharmacokinetics during chronic therapy in HIV-1 infected adolescents and young adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Abacavir (Primary) ; Lamivudine/zidovudine/abacavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 05 Oct 2007 Status changed from in progress to completed.
- 11 Oct 2005 New trial record.